Copeptin Changes After Food Intake

Healthy Adults Clinical Trial

— CoMeal  

Official title:

Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01772914
• Other study ID #: CoMeal 2013
• Status: Completed
• Phase: N/A
• First received: January 17, 2013
• Last updated: May 19, 2014
• Start date: February 2013
• Est. completion date: February 2014

Study information

• Verified date: January 2013
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Swissmedic
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine whether copeptin levels are affected by food intake.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: February 2014
• Est. primary completion date: June 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged over 18 years

Exclusion Criteria:

• Intake of any kind of medication (except birth control pill)

• BMI >30 kg/m2

• Evidence of any acute illness

• History of chronic illness

• Pregnancy

• Known galactosemia or maltose malabsorption

• Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Copeptin
• Healthy Adults

Locations

Country	Name	City	State
Switzerland	University Hospital Basel	Basel	Basel-Stadt

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid		30, 60, 90, 120, 180 minutes after intake of the test liquids	No